Athenex Norepinephrine Injection Recall: Defective Container Risk

Take action

Contact the company & request your remedy

Recalling firmAthenex Pharma Solutions, LLC11342 Main St, N/A · Clarence, NY 14031-1718

No email on file — write to the address above instead.

✎ GovInfoNow plain-language explainer

What happened, in plain English

Athenex Pharma recalls specific lots of Norepinephrine Bitartrate Injection 16 mg per 250 mL. The defective container could lead to medication contamination or injury if the product is used.

Why it’s dangerous

The container is defective, which could cause medication contamination or injury if the product is used. This defect may lead to improper medication delivery or exposure to harmful substances.

Who’s affected

Prescription patients who received the recalled lots of Norepinephrine Bitartrate Injection 16 mg per 250 mL. Healthcare providers using the product are at risk if they have the affected lots.

How to tell if you have this one

Check the lot numbers on the container: F2101634 (exp 3/30/22), F2101665/F2101666 (exp 4/02/22), F2101788/F2101789 (exp 4/26/22), or F2101811/F2101812/F2101815 (exp 4/29/22). The product is a prescription injection for medical use.

Brand
Athenex
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Container
Look for lot numbers F2101634, F2101665, F2101666, F2101788, F2101789, F2101811, F2101812, or F2101815 on the product label.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall states the container is defective, so it is not safe to use. The product should be stopped immediately if you have the affected lots.

What should I do if I have the recalled product?

The recall does not specify a remedy, so contact your healthcare provider or pharmacist for guidance on safe disposal or alternatives.

How can I tell if I have the recalled product?

Check the lot numbers on the container: F2101634 (exp 3/30/22), F2101665/F2101666 (exp 4/02/22), F2101788/F2101789 (exp 4/26/22), or F2101811/F2101812/F2101815 (exp 4/29/22).

Take action

Contact Athenex

We’ve drafted a message you can send Athenex to request your refund or repair — edit it as you like.

✉️ Open in email

Subject: Recall D-0707-2022 — Athenex Athenex

Hello,

I own a Athenex that is covered by recall D-0707-2022 from Athenex.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0707-2022 (March 14, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0707-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.

Athenex Pharma Solutions, LLC recalls Norepinephrine Bitartrate Injection 16 mg per 250 mL added to 0.9% Sodium Chloride, 16 mg, 250 mL excel bag, Rx only,

Recall notice